Selected article for: "cleavage site and insight provide"

Author: Zhang, Liping; Mann, Matthew; Syed, Zulfeqhar; Reynolds, Hayley M.; Tian, E; Samara, Nadine L.; Zeldin, Darryl C.; Tabak, Lawrence A.; Ten Hagen, Kelly G.
Title: Furin cleavage of the SARS-CoV-2 spike is modulated by O-glycosylation
  • Cord-id: fn3xrt3c
  • Document date: 2021_2_5
  • ID: fn3xrt3c
    Snippet: The SARS-CoV-2 coronavirus responsible for the global pandemic contains a unique furin cleavage site in the spike protein (S) that increases viral infectivity and syncytia formation. Here, we show that O-glycosylation near the furin cleavage site is mediated by specific members of the GALNT enzyme family and is dependent on the novel proline at position 681 (P681). We further demonstrate that O-glycosylation of S decreases furin cleavage. Finally, we show that GALNT family members capable of gly
    Document: The SARS-CoV-2 coronavirus responsible for the global pandemic contains a unique furin cleavage site in the spike protein (S) that increases viral infectivity and syncytia formation. Here, we show that O-glycosylation near the furin cleavage site is mediated by specific members of the GALNT enzyme family and is dependent on the novel proline at position 681 (P681). We further demonstrate that O-glycosylation of S decreases furin cleavage. Finally, we show that GALNT family members capable of glycosylating S are expressed in human respiratory cells that are targets for SARS-CoV-2 infection. Our results suggest that O-glycosylation may influence viral infectivity/tropism by modulating furin cleavage of S and provide mechanistic insight into the potential role of P681 mutations in the recently identified, highly transmissible B.1.1.7 variant.

    Search related documents:
    Co phrase search for related documents
    • acceptor peptide and acute respiratory syndrome: 1
    • acute respiratory syndrome and low respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and low respiratory tract: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11